Discover 11 common problems that may arise when cost-cutting compromises the quality of your systematic literature review.
Read More
What actions can you take in light of ISPOR’s top 10 HEOR trends? What impact may these issues have on your HEOR and Market Access strategy?
In this webinar, our experts explore evidence strategies for medical devices, diagnostics and digital health technologies. Have you established the clinical and economic value of your medical device, diagnostic or...
Read More
We are delighted to announce that the second edition of our popular introductory guide: ‘Market access and reimbursement in key European markets’ is now available. Our market access experts have...
Read More
We are delighted to announce that Mtech Access are now a certified NICE Medtech Early Technical Assessment (META) Tool facilitating organisation. Samantha Gillard (Director – HTA), Persefoni Ioannou (Consultant –...
Read More
Maria Dimitrova shares her career journey from public sector roles working with the SMC and SHTC to joining Mtech Access as a Consultant supporting our Pharma and Medtech clients with HTA submissions.
What is an AMCP dossier and how are they used in US market access? Drawing on their extensive experience compiling AMCP dossiers, here, our global market access experts explain when, why and how…
How can you ensure that the market access materials, value proposition and evidence developed by global teams, will resonate for your local audience? In this article, our experts pool their knowledge to share their top tips for successfully taking global materials local.
We explore some of the key themes o the agenda for The MedTech Forum from MDR to Digital Twins
Helen Lilley tells us about her experiences and activities as a medical writer at Mtech Access, supporting projects from local communication materials to global value dossiers to HTA submissions.
